Obesity Weekly News - September 2nd 2025
Viking’s Crash, Orforglipron’s Big Win, Wegovy vs Tirzepatide, Saxenda Generic…
Endocrinology Weekly Update - September 2nd 2025
🧬 Endocrinology Update: Denosumab Approved, New Thyroid Guidelines, AI in…
Obesity Weekly News - August 26th 2025
Viking’s Crash, Orforglipron’s Rise, Semaglutide CV Data, SlimBiome Deal &…
Obesity Weekly News - August 12th 2025
Obesity Update: Ascletis’ ASC30, Hanmi’s CRF2 Breakthrough, Orforglipron’s…
Obesity Weekly News - August 5th 2025
Obesity Update: Radella’s MD-18, Korglutide’s Oral Entry, Liraglutide Launches,…
Obesity Weekly News - July 29th 2025
Obesity Update: Once-Monthly ASC30 Trial, Viking’s Phase III Launch, Generic…
Obesity Weekly News - July 22nd 2025
Obesity Update: CGX-926 Oral Debut, 18% Weight Loss from KAI-9531, Vivani’s…
Obesity Weekly News - July 15th 2025
Obesity Update: Wegovy’s 7.2mg Bid, Rhythm’s Oral Win, TRPV1 Breakthrough &…
Obesity Weekly News - July 8th 2025
China’s Dual GCG/GLP-1 Breakthrough, Innogen’s 2026 Goal, Zepbound's Korea…
Obesity Weekly News - July 1st 2025
Fractyl’s Gene Therapy Breakthrough, Verdiva’s Oral GLP-1 Pipeline, Viking’s…
Obesity Weekly News - June 24th 2025
Eccogene’s Oral GLP-1 Debut, Novo’s 24% Weight Loss Win, Lilly’s Q3 Reveal…
Obesity Weekly News - June 17th 2025
Obesity 🚨 Breakthroughs in Obesity Drug Development You Need to Know! In this…